semaglutide .50 Injection 0.50 mg/0.5 ml semaglutide 50 weight loss Semaglutide:

The class of drugs, which includes Novo Nordisks Ozempic and Wegovy, are associated with the risk of gastrointestinal adverse events when used for weight loss, finds a study published Thursday in JAMA.

Och A, Och M, Nowak R, Podgrska D, Podgrski R

Ten units of semaglutide can produce weight loss in some patients, but individual response varies based on genetics, metabolism, and starting body composition

Insulin resistance and chronic hyperglycemia cause a cascade of pathological events in the brain, including neuroinflammation, impaired neurotransmitter systems and energy metabolism, oxidative stress, and vascular pathologies that ultimately lead to neurodegeneration, loss of synaptic plasticity, brain aging, cognitive impairment, and dementia